Glaucoma Physician’s Post

Orthocell Ltd Ltd (ASX:OCC, OTC:ORHHF) chairman John Van Der Wielen talks with Proactive’s Tylah Tully about milestones achieved by the company this year and shared insights into its growth outlook for 2025r. Van Der Wielen highlighted Orthocell’s focus on execution, emphasising clinical and regulatory successes for key products #Striate+™ and #Remplir™. The company secured approvals in Singapore and is preparing for a significant market entry into the United States, including an #FDA application for Remplir™. Van Der Wielen noted, “Our biggest achievement has been focusing on products that generate revenue while expanding into new markets globally.” Orthocell also achieved its first sales in Singapore following product clearance in October, reflecting strong commercial momentum. Further regulatory submissions for the #SmartGraf #tendonrepair product are pending with the #TGA, targeting the global tendon repair market.... Watch at #Proactive #ProactiveInvestors http://ow.ly/GF7T105RS6Z

Covington Associates is pleased to announce its role as exclusive financial advisor to Lighteum LLC, a San Diego-based innovator in nitinol-based medical component manufacturing, in the sale of its business to MDC (Medical Device Components). Further details on the transaction can be found here: https://lnkd.in/eMYtbQhi

A significant legal victory was recently achieved for our client Silimed Indústria de Implantes. Thanks to the exceptional team efforts of HOFFMANN EITLE's Niels Hölder, Mike Gruber, Anne Schön, and Melanie Schain, the Higher Regional Court of Frankfurt has ruled decisively in favor of SILIMED, granting them full ownership of a patent for a manufacturing process for polyurethane-coated implants. This outcome is notable in several respects, which you can read about here: https://lnkd.in/dG6jRyKx

Swedish company Alleima has acquired Germany-headquartered Endox, a manufacturer of medical components, along with its manufacturing unit in Bielsko-Biala, Poland. Alleima’s president and CEO Goran Bjorkman said: “In line with our strategy for profitable growth and increased resilience, we are focusing on growing stable and profitable sectors such as the medical segment. This will further strengthen our premium position in the medical segment.” Click here for the full article - https://lnkd.in/dNt4a6PR #medtech #medicaldevice #medicalcomponents

Proactive’s Tylah Tully Tully breaks down ‘Just the Facts’ of the latest news from Orthocell Ltd (ASX:OCC, OTC:ORHHF). The company has raised A$17 million to accelerate the US launch of its #Remplir™ #collagenwrap for #peripheralnerverepair. Funds will also support global expansion for both Remplir™ and #Striate+™, a resorbable #collagenmembrane for dental bone and #tissueregeneration. Institutional investors, high net worth individuals and family offices contributed to the raise, resulting in the issuance of up to 28,333,333 million new shares at A$0.60 each. With a strengthened cash position of approximately A$35 million and no debt, Orthocell is positioned to scale up manufacturing, improve automation and grow its market reach across the US, Singapore, Southeast Asia, Canada and the EU/UK. Regulatory processes are advancing with the company on track to submit its US 510(K) application for Remplir this quarter. Watch at #Proactive #ProactiveInvestors #FDA #ASX http://ow.ly/oC80105Nu65

Edwards Lifesciences successfully obtained an injunction against Meril regarding its infringing prosthetic heart valves for Belgium, Bulgaria, Denmark, Germany, Estonia, Finland, France, Italy, Latvia, Lithuania, Luxembourg, the Netherlands, Austria, Portugal, Sweden and Slovenia. KEYWORDS Jurisdiction on infringing acts before 1 June 2023; jurisdiction of the German local divisions; decision on infringement after bifurcation; no stay according to R. 295(c)(i) or (m) RoP; Art. 34 UPCA; third parties` interests; public interest; mechanism to address public needs. Read the -extensive- headnotes and the decision on the EPLAW Patent Blog here: https://lnkd.in/eqWa8d6W [A more detailed summary and analysis will follow]

Osteotec, a Newbury, U.K.-based manufacturer and distributor of specialized medical devices, has announced an exclusive agreement to distribute Cerapedics Inc.'s i-FACTOR bone graft portfolio in the U.K. and Ireland.

We're thrilled to announce that ALBIS has become the sole distributor for Röhm’s PLEXIGLAS® and PLEXIMID® molding compounds in Denmark, Finland, Norway, and Sweden! With our commitment to providing high-quality solutions and excellent customer service, we look forward to delivering innovative products and strong support to our partners in the region. For full details, check out our latest press release https://lnkd.in/eQQYraSr  #Roehm #Distribution #Nordics #Partnership #Roehm #Plexiglas 

H.B. Fuller Company, the largest pureplay adhesives company in the world, announced that it has signed agreements to acquire two leading medical adhesive technology companies: GEM S.r.l. and Medifill Ltd. https://lnkd.in/gaecXfNJ H.B. Fuller Company Australia Pty Limited H.B. Fuller Medical Adhesive Technologies, LLC Gem Chimica S.R.L. Celeste Mastin 

#Acumatica fits #distribution companies like a glove. With broad functionality covering every aspect of business, the deal is sweetened with flexible licensing - no per-user fees! Take a closer look and see why Acumatica should be on your short list. ➡️ https://bit.ly/4aJcELV